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Antigens associated with whole Pasteurella haemolytica biotype A serotype 1, a capsular carbohydrate-
protein extract of the organism, and P. haemolytica leukotoxin were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. Antigens of the electrophoresed preparations were detected by Western
blotting (immunoblotting) with sera from cattle which were either nonvaccinated or vaccinated with live or
killed P. haemolytica vaccines and had variable degrees of resistance to experimental pneumonic pasteurellosis.
Distinct, easily recognizable antigens of these preparations were identified, and the antibody responses to these
antigens were quantified by densitometry. To determine their importance to disease resistance, we then
compared antibody responses with experimental lesion scores. Antibody reactivity to surface antigens which
were significantly correlated with resistance and present in two or more of the preparations were detected at
86, 66, 51, 49, 34, 31, and 16 kilodaltons (kDa). Of these, antibody responses to antigens at 86, 49, and 31 kDa
appeared most important based on their concentration and signfficance levels. Antibody reactivity to leukotoxin
antigens which were significantly correlated with resistance and common with important surface antigens were
detected at 86, 66, and 49 kDa. Antibody responses to unique leukotoxin antigens which were significantly
correlated with resistance were present at 92 and 58 kDa.
Bovine pneumonic pasteurellosis, most commonly caused
by Pasteurella haemolytica biotype A serotype 1, continues
to be a major cause of economic loss to the cattle industry
(19). In experimental studies and field trials, vaccines con-
taining P. haemolytica have been inconsistent in reducing
the incidence and severity of the disease. Experimentally,
most bacterins have induced poor protection and in some
cases have increased the severity of disease (6, 12, 32). More
recently, however, bacterins containing oil adjuvants pro-
duced greater protection than did other bacterins (7). Simi-
larly, experimental studies have demonstrated increased
resistance to challenge exposure after vaccination with live
vaccines (6, 24). Field trials with live vaccines, however,
have demonstrated inconsistent results concerning any eco-
nomic advantages for their use (25, 28).
A variety of antigens which may serve as potential immu-
nogens have been isolated from P. haemolytica. Bacterial
cell wall and capsular materials have been extracted with
saline, sodium salicylate, and potassium thiocyanate (11). A
carbohydrate-protein subunit (CPS) has been further sepa-
rated by chromatography of a saline extract (16). Capsular
carbohydrates and inner and outer membrane proteins of P.
haemolytica have also been purified and characterized (1,
29). Lipopolysaccharide, which has typical endotoxin prop-
erties (8, 9, 26), and an exotoxin (leukotoxin [LKT]), which
is toxic to ruminant leukocytes (2), have also been isolated
from the organism.
Several of these bacterial components stimulate antibody
responses which appear to be associated with resistance to
disease. High antibody levels in serum to surface antigens in
saline, sodium salicylate, and potassium thiocyanate ex-
tracts of P. haemolytica have been associated with enhanced
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resistance to experimental pneumonic pasteurellosis (5, 20,
33). Serum antibodies to CPS were correlated with reduced
lesion severity following experimental challenge (A. W.
Confer, K. R. Simons, R. J. Panciera, A. J. Mort, and D. A.
Mosier, Am. J. Vet. Res., in press). Anti-LKT antibodies
have often been considered to be important for enhancing
resistance to this disease. LKT neutralization assays and an
enzyme-linked immunosorbent assay (ELISA) have been
used to detect high anti-LKT antibody levels in serum of
naturally and experimentally infected cattle which were
resistant to the disease (4, 13, 21). Development of an
efficacious subunit vaccine would be aided by the identifica-
tion of the important antigenic components of these and
other appropriate extracts of P. haemolytica.
The purpose of this study was to evaluate the antibody
response of cattle to capsular, surface membrane, and LKT
antigens of P. haemolytica. Sera from cattle which had been
part of experimental P. haemolytica vaccine studies were
tested against these preparations by Western blot (immuno-
blot) analysis. Reactivity of these sera to antigens on the
blots was quantified by densitometry and compared with
experimental lesion scores in the cattle to identify specific
antigens of P. haemolytica which may be important for
stimulating immunity.
MATERIALS AND METHODS
Bacteria. Lyophilized P. haemolytica serotype 1, orig-
inally isolated from a case of pneumonic pasteurellosis, was
reconstituted for use in these studies (10). Bacteria were
reconstituted in phosphate-buffered saline (PBS) and grown
on brain heart infusion agar supplemented with 5% bovine
blood in 5% CO2 at 37°C. Cultures used for vaccine prepa-
ration, for experimental challenge, and for inoculation of
broth for LKT production were grown for 18 to 22 h.
Cultures used for extraction of CPS were grown for 6 h.
Serum samples and lesion scores. Ten serum samples from
711
712 MOSIER ET AL.
TABLE 1. Comparison of disease resistance with antibody responses to antigens of WB, CPS, and LKTI
Antigen
Peak no. WB CPS LKT
MWb rC P MW r P MW r
1 116 0.276 0.085 86 0.557 <0.001 116 0.263 0.100
2 110 0.248 0.123 80 0.474 0.002 105 0.080 0.623
3 86 0.355 0.024 66 0.625 <0.001 100 0.277 0.084
4 78 0.177 0.274 62 0.043 0.793 92 0.557 <0.001
5 71 0.524 <0.001 51 0.409 0.009 86 0.572 <0.001
6 69 0.158 0.330 49 0.678 <0.001 71 0.280 0.080
7 62 0.038 0.814 43 0.379 0.016 66 0.336 0.034
8 58 0.180 0.266 40 0.356 0.024 58 0.338 0.033
9 55 0.115 0.482 38 0.283 0.077 49 0.342 0.031
10 51 0.660 <0.001 34 0.411 0.008 31 0.197 0.223
11 50 0.303 0.057 31 0.674 <0.001 25 0.299 0.061
12 43 0.167 0.303 27 0.227 0.159 15 0.146 0.370
13 41 0.272 0.090 16 0.346 0.029 10 0.238 0.140
14 39 0.149 0.357
15 34 0.363 0.021
16 31 0.569 <0.001
17 25 0.167 0.303
18 23 0.221 0.171
19 22 0.316 0.047
20 20 0.239 0.137
21 18 0.273 0.089
22 16 0.387 0.014
a Estimates of disease resistance are derived from mean lesion scores determined following experimental transthoracic exposure to P. haemolytica for each
vaccine group and PBS controls.
b MW, Molecular weight x 103.
c r, Correlation coefficient.
each of four groups of 160- to 200-kg beef calves were used
for this study. All these calves had been used in experiments
to evaluate the effect of various vaccines on resistance to
experimental pneumonic pasteurellosis (6, 7, 24). On days 0
and 7 of the experiments, each calf received an injection of
5 ml of PBS, 5 ml of a bacterin containing 109 CFU of
Formalin-killed P. haemolytica in aluminum hydroxide adju-
vant (ALH), 5 ml of a bacterin containing 109 CFU P.
haemolytica in Freund incomplete adjuvant (FIA), or 5 ml of
109 CFU of live P. haemolytica (Live). Sera were collected
on day 21 and stored at -20°C. Calves were challenged on
day 21 by transthoracic injection of approximately 5 x 109
CFU of P. haemolytica in PBS (23). Calves were euthanized
on day 25, and lung lesions were evaluated to determine the
pulmonary resistance to experimental challenge. Numerical
scores ranging from 0 (no lesion) to 20 (severe lesion) based
on morphological criteria were assigned to each calf (24).
These criteria consisted of the size of the lesion at its most
intense focus, the amount of interlobular extension of the
lesion from this focus, the degree of edema in the challenge-
exposed lobe, the amount of translobular extension of the
lesion, and the extent of pleuritis associated with the lesion.
Calves with lesion scores of 5 or less were considered
resistant. Mean lesion scores by vaccine type were 14.8 for
PBS controls, 10.6 for ALH-vaccinated calves, 3.4 for
FIA-vaccinated calves, and 3.6 for Live-vaccinated calves.
Significant differences (P < 0.05) were present between
lesion scores for calves receiving Live or FIA compared
with PBS or ALH vaccines. No significant differences were
present between lesion scores for calves receiving PBS
compared with ALH or Live compared with FIA vaccines.
Antigens. Fresh 18- to 22-h-old cultures of P. haemolytica
serotype 1 suspended to a concentration of 109 CFU in PBS
were utilized as the whole-bacteria somatic antigen (WB).
The CPS was prepared by warm saline extraction of 6-h-old
cultures of P. haemolytica followed by chromatofocusing of
the extract as previously described (16). LKT was prepared
by inoculation of brain heart infusion broth with 18- to
22-h-old cultures of P. haemolytica. Following a 4.5-h incu-
bation at 37°C on a rotary shaker, bacteria were pelleted and
suspended in RPMI 1640 medium for an additional 1-h
incubation. The supernatant was then precipitated by the
addition of 313 g of ammonium sulfate per liter. The resulting
pellet was suspended in 10 mM Tris hydrochloride buffer,
and toxicity of the extract was confirmed by lactate dehy-
drogenase release assays on cells from a bovine B-lympho-
cyte cell line (BL-3 cells) (K. D. Clinkenbeard, D. A.
Mosier, A. L. Timko, and A. W. Confer, Am. J. Vet. Res.,
in press).
Electrophoresis and immunoblotting. Antigen extracts
were subjected to preparative sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis. Samples were adjusted to a
final protein concentration of 1 mg/ml, denatured, reduced,
and separated on vertical slab gels by discontinuous sodium
dodecyl sulfate-polyacrylamide gel electrophoresis with 2%
stacking and 10% resolving gels (16). Proteins from the gels
were then electrophoretically transferred onto a nitrocellu-
lose membrane (30). Approximately 5-mm-wide strips were
cut from the membrane and placed in individual troughs of a
Plexiglas tray. Each strip was sequentially reacted with a
1:25 dilution of the serum to be evaluated, affinity-purified
horseradish peroxidase-labeled goat anti-bovine immuno-
globulin G (Kirkegaard and Perry Laboratories Inc., Gaith-
ersburg, Md.) at a 1:800 dilution, and 4-chloro-2-naphthol
and hydrogen peroxide for color development. Serum from a
steer which was hyperimmunized with live P. haemolytica
and had high absorbance values in an ELISA to whole P.
haemolytica (positive control) and serum from a steer with
low serum reactivity to the same ELISA (negative control)
were evaluated with each gel and blot. A densitometer in the
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FIG. 1. Westem blot and densitometer scan profile demonstrat-
ing the antibody response to antigens in the CPS extract of P.
haemolytica. Peak numbers are assigned to antibody responses
which were quantitated and statistically evaluated. Antigens were
electrophoresed from left to right and detected with serum from a
calf which was injected with live P. haemolytica.
reflectance mode was used to scan each nitrocellulose strip
(model 620 video densitometer; Bio-Rad Laboratories, Rich-
mond, Calif.). From the resulting scans, major separated
antigens were identified and the total optical density (OD-t)
was determined for each antigen by integration of the total
area under the corresponding identified peak from the scan
profile (1-D Gel Analyst; Bio-Rad Laboratories). Criteria
used for the determination of major antigens were that the
antigenic bands were distinct and easily identified in the
positive control and were not prominent in the negative
control and that the location of the band could be identified
with surety in all four experimental groups. The OD-t values
were considered to be measurements of antibody levels to
the particular antigen composing each band. Molecular
weights of the antigens were determined by comparing their
relative mobilities with the relative mobilities of proteins of
known molecular weight.
Statistical analysis. Mean OD-t values for identified peaks
from each antigenic preparation were determined for each of
the four vaccine groups. Multiple t tests were used to
compare the mean OD-t values between vaccines within
each antigen group. Unequal variances were used for calcu-
lating t test values. Linear regression was used to compare
experimental lesion scores with OD-t values for each iden-
tified peak for each of the five antigen preparations. Linear
correlation for these same variables was evaluated by the
Pearson product-moment. The significance level for all anal-
yses was P < 0.05 unless otherwise stated.
RESULTS
The total number of antigens identified was 22 for WB and
13 each for CPS and LKT. Comparison of the OD-t for each
identified band with experimental lesion scores demon-
strated significant correlation between these variables for
certain antigens in each preparation (Table 1). Antibodies to
the largest number of antigens which were significantly
correlated with low experimental lesion scores (resistance)
were present in CPS. These consisted of 10 total antigens
corresponding to scan profile peaks 1 (86 kilodaltons [kDa]),
2 (80 kDa), 3 (66 kDa), 5 (51 kDa), 6 (49 kDa), 7 (43 kDa), 8
(40 kDa), 10 (34 kDa), 11 (31 kDa), and 13 (16 kDa) (Fig. 1).
The antigens at 86, 66, 49, and 31 kDa were also significant
at P < 0.001 (highly significant). For WB, antibodies to
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FIG. 2. Western blot and densitometer scan profile demonstrat-
ing the antibody responses to antigens in the WB P. haemolytica
preparation. Peak numbers are assigned to antibody responses
which are quantitated and statistically evaluated. Antigens were
electrophoresed from left to right and detected with serum from a
calf which was injected with live P. haemolytica.
kDa), 5 (71 kDa), 10 (51 kDa), 15 (34 kDa), 16 (31 kDa), 19
(25 kDa), and 22 (16 kDa) significantly correlated with
resistance (Fig. 2). Antibodies to the antigens at 71, 51, and
31 kDa were highly significant. Antibodies to five LKT
antigens corresponding to scan profile peaks 4 (92 kDa), 5 (86
kDa), 7 (66 kDa), 8 (58 kDa), and 9 (49 kDa) were signifi-
cantly correlated with resistance (Fig. 3); the two at 92 and
86 kDa were also highly significant.
Antibodies to antigens which were significantly correlated
with resistance and were common between CPS and WB
were present at 86, 51, 34, 31, and 16 kDa. Of these, the
31-kDa antigen was highly significant for both extracts. Also
in common with the antigen at 86 kDa was an LKT antigen
with antibodies which were significantly correlated with
resistance. Common antigens at 66 and 49 kDa were present
between CPS and LKT, but there were no significant anti-
bodies to corresponding antigens for WB. Unique antigens
were present in CPS at 80, 43, and 40 kDa, at 71 and 25 kDa
in WB, and at 92 and 58 kDa in LKT.
The mean OD-t values for the 10 antigens in CPS which
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FIG. 3. Western blot and densitometer scan profile demonstrat-
ing the antibody responses to antigens in the P. haemolytica LKT
preparation. Peak numbers are assigned to antibody responses
which were quantitated and statistically evaluated. Antigens were
electrophoresed from left to right and detected with serum from a
calf injected with live P. haemolytica.
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TABLE 2. Antibody responses significantly correlated with resistance to antigens in CPSa
Mean OD + SD
Peak no. MWb
PBS Live FIA ALH
1 86 0.794 ± 0.393 1.355 ± 0.404 1.506 ± 0.516 1.205 ± 0.545
2 80 1.718 ± 0.669 2.969 ± 0.618 2.863 ± 0.794 2.607 ± 0.726
3 66 0.582 ± 0.458 1.453 ± 0.350 1.072 ± 0.376 0.780 ± 0.490
5 51 0.249 ± 0.145 0.726 ± 0.328 0.765 ± 0.415 0.903 ± 0.388
6 49 2.116 ± 1.072 4.019 ± 0.585 3.764 ± 0.744 2.935 ± 0.678
7 43 0.398 ± 0.285 0.609 ± 0.551 0.863 ± 0.495 0.626 ± 0.224
8 40 0.680 ± 0.493 1.258 ± 0.618 1.021 ± 0.426 0.932 ± 0.298
10 34 0.120 ± 0.172 0.642 ± 0.245 0.582 ± 0.310 0.868 ± 0.566
11 31 0.338 ± 0.481 1.699 ± 0.512 1.975 ± 1.101 0.710 ± 0.753
13 16 0.636 + 0.670 1.213 ± 0.437 1.456 ± 0.434 1.330 ± 0.317
a Antibody responses = mean OD ± standard deviation with 10 samples per vaccine group. Groups evaluated include calves injected with PBS, 109 CFU of
live P. haemolytica (Live), P. haemolytica bacterin in FIA, and P. haemolytica bacterin in ALH.
b MW, Molecular weight x 103.
tance are shown in Table 2. Live-vaccinated calves had
significantly greater antibodies compared with PBS controls
to all antigens except the one at 43 kDa. FIA-vaccinated
calves had significantly greater antibodies than PBS controls
to all antigens except at 40 kDa. ALH-vaccinated calves had
antibodies to antigens at 86, 80, 51, 34, and 16 kDa which
were significantly increased compared with PBS controls.
There was no significant difference between ALH-vacci-
nated calves and PBS controls for antibodies to antigens at
66, 49, 43, 40, and 31 kDa. FIA-vaccinated calves had
significantly greater antibodies to the 31-kDa antigen com-
pared with ALH-vaccinated calves. Significantly increased
antibodies were present in Live- compared with ALH-
vaccinated calves to antigens at 66, 49, and 31 kDa. Signif-
icantly different antibody reactivity was not present for any
antigen when comparing Live- and FIA-vaccinated calves.
The mean OD-t values for the seven antigens in WB which
had antibody responses significantly correlated with resis-
tance are shown in Table 3. Antibodies to five of these
antigens were significantly greater in Live-vaccinated calves
compared with PBS controls. Antibodies to the antigens at
86 and 31 kDa were not significantly different. For FIA-
vaccinated calves, antibodies to all but the antigen at 86 kDa
were significantly greater than antibodies for PBS controls.
With ALH-vaccinated calves, however, only antibodies to
the antigens at 51 and 31 kDa were significantly greater than
antibodies to the same antigens for PBS controls. Antibodies
to the antigen at 31 kDa were significantly greater for FIA-
compared with Live-vaccinated calves. Live-vaccinated
calves had significantly greater antibodies compared with
ALH vaccinates for the antigen at 16 kDa.
The mean OD-t values for the five antigens in LKT which
had antibody responses significantly correlated with resis-
tance are shown in Table 4. FIA-vaccinated calves had
significantly greater antibodies compared with PBS controls
to all of these antigens. Live-vaccinated calves had signifi-
cantly greater antibodies compared with PBS controls for
the antigens at 92, 86, and 58 kDa but not those at 66 or 49
kDa. Antibodies in ALH-vaccinated calves were not signif-
icantly greater than antibodies for PBS controls for any
antigens. Significant differences were not detected between
antibodies for any antigen when comparing Live-, FIA-, and
ALH-vaccinated calves.
DISCUSSION
In experimental P. haemolytica vaccine studies, calves
vaccinated with live vaccines and bacterins in oil adjuvants
had significantly greater resistance to challenge exposure
than did nonvaccinated animals and calves vaccinated with
bacterins in ALH adjuvants (7). The presence of LKT-
neutralizing antibodies, which are induced by live vaccines,
was hypothesized to be an important factor in inducing
resistance to pneumonic pasteurellosis (24, 31). However,
similar protection was afforded by FIA bacterins in the
absence of LKT-neutralizing antibodies, indicating that an-
tigens other than LKT are also important in protection (7).
The results of the present study demonstrated the presence
of antigens in CPS and WB as well as LKT which appear to
be associated with an immune response and enhanced resis-
tance to pneumonic pasteurellosis.
Previous studies with an ELISA which detects antibodies
to P. haemolytica CPS showed significant correlation be-
tween resistance and antibody response to this extract (7).
The precise antigens in the extract responsible for resis-
tance, however, were not determined. In the present study,
TABLE 3. Antibody responses significantly correlated with resistance to antigens in WB'
Mean OD + SD
Peak no. MWb
PBS Live FIA ALH
3 86 0.350 ± 0.256 0.546 ± 0.250 0.588 ± 0.467 0.754 ± 0.250
5 71 0.312 ± 0.379 0.881 ± 0.466 0.690 ± 0.382 0.433 ± 0.463
10 51 0.647 ± 0.497 1.727 ± 0.702 1.738 ± 0.532 1.382 ± 0.474
15 34 0.094 ± 0.123 0.785 ± 0.623 0.460 ± 0.367 0.355 ± 0.370
16 31 1.142 ± 0.470 1.699 ± 0.647 2.760 t 0.647 2.066 t 0.526
17 25 0.435 ± 0.271 1.053 ± 0.667 1.290 ± 0.600 0.851 ± 0.635
22 16 0.105 ± 0.126 0.409 ± 0.251 0.382 ± 0.301 0.153 t 0.174
a Antibody responses = mean OD + standard deviation with 10 samples per vaccine group.
b MW, Molecular weight x 103.
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TABLE 4. Antibody responses significantly correlated with resistance to antigens in LKT'
Mean OD ± SD
Peak no. MWb
PBS Live FIA ALH
4 92 0.011 ± 0.027 0.078 ± 0.042 0.075 ± 0.069 0.046 ± 0.043
5 86 0.221 ± 0.193 0.458 ± 0.155 0.517 ± 0.158 0.354 ± 0.227
7 66 0.195 ± 0.167 0.352 ± 0.300 0.339 ± 0.164 0.196 ± 0.155
8 58 0.217 ± 0.315 0.686 ± 0.427 0.510 ± 0.257 0.384 ± 0.413
9 49 0.144 ± 0.250 0.469 ± 0.443 0.577 ± 0.415 0.333 ± 0.274
a Antibody responses = OD + standard deviation with 10 samples per vaccine group.
b MW, Molecular weight x 103.
10 antigens within CPS stimulated antibodies which were
significantly correlated with resistance. Vaccination with
both Live and FIA vaccines stimulated a significantly greater
serum antibody response to nine of these antigens compared
with PBS controls. In contrast, ALH vaccination stimulated
a significantly greater serum antibody response to only five
of these important antigens when compared with PBS con-
trols. The more severe experimental lesions in the ALH-
vaccinated calves compared with those in Live- and FIA-
vaccinated calves are most likely due to differences in the
adjuvants. Antibody responses to three CPS antigens (66,
49, and 31 kDa) had highly significant correlations with
resistance. Compared with ALH-vaccinated calves, calves
receiving Live or FIA vaccines had significantly higher
antibody levels to all three of these antigens or the 31-kDa
antigen, respectively. Additionally, the 49- and 31-kDa anti-
gens were either highly immunogenic or present in high
concentrations, based on OD-t values. Based on these
differences, these CPS antigens may be particularly impor-
tant immunogens.
Antibody responses to five antigens present in both CPS
and WB (86, 51, 34, 31, and 16 kDa) were significantly
correlated with resistance in both preparations. These com-
mon antigens should be expected since CPS is an extract
containing many of the surface antigens present in WB. The
antibody responses to unique antigens in WB (71 and 25
kDa) were significantly greater in calves receiving Live and
FIA vaccines but not in ALH-vaccinated calves compared
with PBS controls, suggesting a potential role for these
antigens in resistance to disease. Recombinant plasmids
coding for a specific P. haemolytica serotype 1 antigen have
been identified (14). This cloned antigen was expressed and
located on the surface of Escherichia coli and may represent
a surface antigen possibly associated with resistance to
pneumonic pasteurellosis. The relationship between this
antigen and the surface antigens identified in the current
study is unknown.
Determination of serum antibody to LKT by ELISA and
LKT neutralization assays has demonstrated a positive
correlation between resistance to challenge exposure and
high anti-LKT antibody levels in serum (4, 13, 21). Use of
LKT-containing supematants of P. haemolytica as an immu-
nizing agent, however, has shown that the induction of
LKT-neutralizing antibodies alone is insufficient for provid-
ing adequate protection against pneumonic pasteurellosis
(27). A 105-kDa LKT has been purified from P. haemolytica
(3). LKT has also been expressed from E. coli recombinant
clones and characterized as a 100-kDa protein (17). Addi-
tionally, the DNA fragment coding for this LKT has been
isolated and sequenced (18). Although a prominent antibody
response to a 100- to 105-kDa antigen was detected in the
present study, there was no significant correlation between
this response and resistance to challenge. At 92 kDa, how-
ever, a highly significant antibody response to an antigen
unique to LKT was detected. This antigen may be similar to
the 95-kDa polypeptide proposed to be the primary proteo-
lytic breakdown product of the 105-kDa LKT (3). In the
present study, antibodies to the 92-kDa antigen as well as to
another unique LKT antigen at 58 kDa were significantly
greater in both Live- and FIA-vaccinated calves compared
with PBS controls. Because FIA-vaccinated calves, which
should not have received much LKT and do not develop
LKT-neutralizing antibodies, responded to these two anti-
gens similarly to calves receiving Live vaccines, which
should have received substantially more LKT and do de-
velop LKT-neutralizing antibodies, it is possible that these
antigens share common epitopes with surface antigens of P.
haemolytica. The possibility that LKT consists of both a
secreted component and a component which is derived from
part of the surface membrane structure of P. haemolytica
should be considered. Some evidence for this possibility has
been shown by the detection of leukotoxic activity in cell
pellets as well as supernatants of P. haemolytica (K. D.
Clinkenbeard, unpublished data). Active LKT may consist
of an immunogenic but nonprotective complex of capsular or
membrane components of P. haemolytica combined with a
secreted protein which is actively released from the organ-
ism or is elaborated as a result of normal membrane turnover
during logarithmic growth. Degradation of this complex may
result in loss of leukotoxic activity but expose immunogenic
and protective epitopes of the major degradation product.
In a previous study, a 57-kDa antigen derived from a
biochemically separated LKT preparation was identified
(22). This may correspond to the unique 58-kDa antigen of
the present study which had antibody reactivity which was
significantly correlated with resistance. Low-molecu-
lar-weight antigens which most likely represent degradation
products of the larger LKT components have been described
within several LKT preparations (3, 15, 22). It appears that
some of these degradation products (most notably those at
92 and 58 kDa) may be important for stimulating antibodies
associated with resistance to pneumonic pasteurellosis.
Some LKT antigens with significant antibody reactivity (86,
66, and 49 kDa) were common with similar antigens in CPS.
These antigens in LKT most likely represent surface anti-
gens which are present in both CPS and LKT preparations.
The results of this study identified several antigens of P.
haemolytica serotype 1 which may be important for stimu-
lating immunity to pneumonic pasteurellosis. Antigens of
probable surface origin which were important in two or more
of the extracts were present at 86, 66, 51, 49, 34, 31, and 16
kDa. Of these antigens, those at 86, 49, and 31 kDa appear to
be the best prospects for future experimental studies based
on their concentrations, the significance levels of the anti-
body responses to these antigens when compared with lesion
scores, or their importance in more than one antigen prepa-
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ration. Additionally, a variety of unique antigens which may
be important immunogens were identified. Notably, antigens
at 92 and 58 kDa which were unique to LKT may represent
protective portions of P. haemolytica LKT. Recognition of
the protective antigens of P. haemolytica will enable future
studies to more specifically isolate antigens which are not
only immunogenic, but more importantly, capable of en-
hancing disease resistance.
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